Our mission
Worldwide, the incidence of cancer is growing, as life expectancy increases. Current imaging tools have their limitations as they are not suitable to provide the necessary information during diagnosis. Scinvivo aims to revolutionize cancer diagnostics and care by providing medical professionals with the next gen minimal invasive imaging platform. This imaging platform fills the gap that is left open by the current imaging technologies, as current technologies are unable to show the anatomical structure of the tissue during endoscopic procedures.
Scinvivo solves unmet needs for Payers, Patients and Doctors

Best possible care for patients, while costs are reduced

Improved quality of life by reducing invasive surgeries

Improved cancer diagnosis and treatment
Our solution
Scinvivo first focusses on the medical needs in bladder cancer. Scinvivo’s forward-looking OCT-catheter provides the answer by giving urologists real time ultra high resolution (a few micrometers) insight in the anatomical structure during diagnosis (cystoscopy).
Classical cystoscopy image on which a tumor is visible
Different stages (TIS-T4) of bladder cancer
Our Product


In the image below the first results of our second generation OCT probes is visible. An OCT image (left) made with one of our probes of porcine bladder tissue (right). The different layers of the bladder wall are clearly visible, as well as small blood vessels running through it.

Our team


CTO
Maaike de Jong has worked as CTO for Scinvivo since it was founded. As CTO, she is continuously developing the imaging platform and arranging the (pre)-clinical trials. Next to that, she secures funding for Scinvivo in the form of grants, loans, and new investments. She holds a MSc in Biomedical Engineering and worked in Boston at Massachusetts General Hospital to specialize in Optical Coherence Tomography and its endoscopic applications. Maaike has an extensive international netwerk regarding OCT technologies and urology.
She has a strong belief that the imaging platform Scinvivo develops will be a game changer in cancer diagnostics. She is not afraid of a challenge, and is always looking for new information that will help in increasing the success of the imaging platform.


CEO
Marijn van Os is CEO at Scinvivo, since October 2019 and co-founded of Scinvivo in 2016. As an entrepreneur he also founded Innoluce in 2010 as a spin-off of Royal Philips, including acquiring the main MEMS mirror IPR. Marijn successfully managed the acquisition of Innoluce by Infineon in 2016 for the automotive applications. Prior to this acquisition the medical assets, IPR and knowhow was transferred to Scinvivo. Marijn holds a PhD in mechanical engineering and continued his working career at Philips where he held different positions as technologist and development manager within The Netherlands and in the Czech Republic. Marijn has an extensive international network in the MEMS space and in the medical space for Urology.
Marijn is always looking for opportunities to improve and challenge the status quo and as such he is convinced that with the solution of Scinvivo the unmet needs in the cancer diagnostics & care will be improved significantly for all stakeholders, but in particular for the patients.


COO
Camile van der Heijden joined Scinvivo in June 2018 and was appointed as COO in november 2019. Camile studied Biomedical Engineering (Bachelor) and Medical Engineering (Master). Camile holds a PDEng title Qualified Medical Engineer from the Stan Ackermans Institute. Prior to working for Scinvivo, Camile was employed at the Maxima Medical Center. There he worked on designing an improved educational simulation environment for use during training of the Neonatal Invasive Care Staff. Camile has a great network in the medical field in the Netherlands and is able to oversee the impact of product design on the medical regulatory application.
He believes technology has the potential to change lives for the better and it inspires and motivates him to help make that potential a reality. Scinvivo’s product is a prime example of this core belief: technology that can mean the difference between life and death.


Medical Imaging Engineer
Malak Aljourishi joined Scinvivo as a Medical Imaging Engineer. Her role is to implement image processing algorithms for OCT data acquired by Scinvivo catheter. She contributes to the design of graphical user interfaces for clinical specialists. She holds a master degree in Biomedical Engineering, and has working experience in both the Netherlands and Germany. She worked at the AUMC where she used image processing techniques to visualize lesion properties after brain strokes.
She is convinced that imaging enhancement techniques and AI will improve cancer diagnostics, and that Scinvivo will turn this into reality. She loves learning new programming languages and using them to develop a user interface that will be intuitive to doctors all over the world.
News
Contact us
We would be happy to tell you more about our products
Our location
Torenallee 20 5617 BC Eindhoven
Call us
+31 6 4609 3997
Mail us
info@scinvivo.com